On-Cell mAb Screening (OCMS™)
For more than four decades, conventional hybridomas have been the mainstay for monoclonal antibody (mAb) discovery. Isn’t it time for an upgrade?
On-Cell mAb Screening (OCMS) uses fluorescent antigen binding to quickly identify cells expressing high value mAbs, rendering limiting dilution cloning and ELISAs obsolete. TELL ME MORE.